首页> 外国专利> MARKER FOR PREDICTING THERAPEUTIC EFFECT ON TYPE C HEPATITIS, METHOD FOR PREDICTING THERAPEUTIC EFFECT ON TYPE C HEPATITIS, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR TYPE C HEPATITIS

MARKER FOR PREDICTING THERAPEUTIC EFFECT ON TYPE C HEPATITIS, METHOD FOR PREDICTING THERAPEUTIC EFFECT ON TYPE C HEPATITIS, AND PROPHYLACTIC OR THERAPEUTIC AGENT FOR TYPE C HEPATITIS

机译:预测C型肝炎治疗效果的标志物,预测C型肝炎治疗效果的方法以及C型肝炎的预防或治疗药物

摘要

PPROBLEM TO BE SOLVED: To provide a highly accurate method for predicting therapeutic effect on type C hepatitis in PEGylated IFN/RBV combination therapy. PSOLUTION: There are disclosed a marker for predicting the therapeutic effect on type C hepatitis wherein the marker is an oligonucleotide or polynucleotide existing on the human genome and includes one or more kinds selected from genetic polymorphisms represented by a specific sequence or linkage disequilibriums (R20.8) therewith, and a method for predicting the therapeutic effect on type C hepatitis using the marker. PCOPYRIGHT: (C)2011,JPO&INPIT
机译:

要解决的问题:提供一种预测PEG化IFN / RBV联合疗法对C型肝炎的治疗效果的高精度方法。

解决方案:公开了一种预测对C型肝炎的治疗效果的标记物,其中该标记物是存在于人类基因组上的寡核苷酸或多核苷酸,并且包括一种或多种选自特定序列或连锁不平衡的遗传多态性的标记。 (R2> 0.8),以及使用该标志物预测对C型肝炎的治疗效果的方法。

版权:(C)2011,日本特许厅&INPIT

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号